Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Recurrent Malignant Glioma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent Malignant Glioma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Recurrent or Metastatic Head and Neck cancer - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent or Metastatic Head and Neck cancer - Epidemiology Forecast to 2032' report delivers an in-depth underst...

January 2022 60 pages

Recurrent or Metastatic Head and Neck cancer - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent or Metastatic Head and Neck cancer- Market Insights, Epidemiology, and Market Forecast-2032' report de...

January 2022 200 pages

Recurrent or Metastatic HER2-Overexpressing Solid Tumors - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent or Metastatic HER2-Overexpressing Solid Tumors - Epidemiology Forecast to 2032' report delivers an in-d...

January 2022 60 pages

Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast to 2032' report delivers an in-depth und...

January 2022 60 pages

Recurrent Pericarditis - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent Pericarditis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Recurrent Pericarditis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent Pericarditis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth und...

January 2022 200 pages

Refractive Errors - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractive Errors - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...

January 2022 60 pages

Refractory Angina - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Angina- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understa...

January 2022 200 pages

Refractory Epilepsy - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Epilepsy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...

January 2022 60 pages

Refractory Epilepsy - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Epilepsy- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth unders...

January 2022 200 pages

Refractory Metastatic Melanoma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Metastatic Melanoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Refractory Metastatic Melanoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Metastatic Melanoma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-d...

January 2022 200 pages

Refractory Multiple Myeloma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Multiple Myeloma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...

January 2022 60 pages

Refractory Multiple Myeloma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Multiple Myeloma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-dept...

January 2022 200 pages

Refractory Status Epilepticus (RSE) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Status Epilepticus (RSE) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Refractory Status Epilepticus (RSE) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Status Epilepticus (RSE)- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an...

January 2022 200 pages

Relapsed B-Cell Small Lymphocytic Lymphoma - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed B-Cell Small Lymphocytic Lymphoma - Epidemiology Forecast to 2032' report delivers an in-depth understan...

January 2022 60 pages

relapsed and refractory CD5-expressing T cell lymphomas - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'relapsed and refractory CD5-expressing T cell lymphomas - Epidemiology Forecast to 2032' report delivers an in-de...

January 2022 60 pages

Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032' report delivers an in-...

January 2022 60 pages

Relapsed or Refractory Mycosis Fungoides - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed or Refractory Mycosis Fungoides - Epidemiology Forecast to 2032' report delivers an in-depth understandi...

January 2022 60 pages

Relapsed or Refractory Mycosis Fungoides - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Relapsed or Refractory Mycosis Fungoides- Market Insights, Epidemiology, and Market Forecast-2032' report delive...

January 2022 200 pages

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) - Epidemiology Forecast to 2032' report delivers an in-depth...

January 2022 60 pages

relapsed/refractory Epstein-Barr virus (EBV) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'relapsed/refractory Epstein-Barr virus (EBV) - Epidemiology Forecast to 2032' report delivers an in-depth underst...

January 2022 60 pages

Relapsed/Refractory Epstein Barr Virus - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed/Refractory Epstein Barr Virus - Epidemiology Forecast to 2032' report delivers an in-depth understanding...

January 2022 60 pages

Relapsed/Refractory Epstein Barr Virus - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Relapsed/Refractory Epstein Barr Virus- Market Insights, Epidemiology, and Market Forecast-2032' report delivers...

January 2022 200 pages

relapsed/refractory (R/R) Epstein-Barr virus (EBV) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'relapsed/refractory (R/R) Epstein-Barr virus (EBV)- Market Insights, Epidemiology, and Market Forecast-2032' rep...

January 2022 200 pages

Relapsing Refractory Multiple Myeloma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsing Refractory Multiple Myeloma - Epidemiology Forecast to 2032' report delivers an in-depth understanding...

January 2022 60 pages

Relapsing Refractory Multiple Myeloma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Relapsing Refractory Multiple Myeloma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers...

January 2022 200 pages

REM poisioning - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'REM poisioning - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...

January 2022 60 pages

REM Sleep Behavior Disorder - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'REM Sleep Behavior Disorder - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...

January 2022 60 pages

REM Sleep Behavior Disorder - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'REM Sleep Behavior Disorder- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-dept...

January 2022 200 pages

Renal Fanconi Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Renal Fanconi Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth und...

January 2022 200 pages

Renal Impairment - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Renal Impairment - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Renal insufficiency - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Renal insufficiency - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...

January 2022 60 pages

Renal Tubular Acidosis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Renal Tubular Acidosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Renal vasculitis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Renal vasculitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Renal Vasculitis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Renal Vasculitis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understan...

January 2022 200 pages

Resistant Hypertension - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Resistant Hypertension - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Respiratory Distress Syndrome - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Respiratory Distress Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the d...

January 2022 60 pages

Respiratory Distress Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Respiratory Distress Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-de...

January 2022 200 pages

Restless Leg Syndrome - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Restless Leg Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Restless Leg Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Restless Leg Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth unde...

January 2022 200 pages

Retinal Detachment Disorder - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Retinal Detachment Disorder - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...

January 2022 60 pages

Retinal Detachment Disorder - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Retinal Detachment Disorder- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-dept...

January 2022 200 pages

Retinal Edema - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Retinal Edema - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...

January 2022 60 pages

Retinal Edema - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Retinal Edema- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understandin...

January 2022 200 pages

Retinal Neovascularization(NV) - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Retinal Neovascularization(NV) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Retinoic acid receptor agonists - Pipeline Insight, 2022

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Retinoic Acid Receptor (RARs) Agonist - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companie...

January 2022 60 pages

Retinopathy of Prematurity - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Retinopathy of Prematurity- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1